Collaboration Is Key for Successful Treatment of Youth-Onset Type 2 Diabetes

Abstract Type 2 diabetes (T2D) is increasing in U.S. adolescents, particularly those of ethnic and racial minority groups. Risk factors for youth-onset T2D include obesity, family history of T2D, poor diet, lack of exercise, and poverty. The onset of diabetes-related complications is accelerated in...

Full description

Saved in:
Bibliographic Details
Published in:Journal of adolescent health 2017-04, Vol.60 (4), p.360-362
Main Authors: Folsom, Lisal J., M.D, Hannon, Tamara S., M.D., M.S
Format: Article
Language:English
Subjects:
Adolescent
Adolescent Health - trends
Adolescents
Clinical research
Clinical trials
Collaboration
Complications
Diabetes
Diabetes Mellitus, Type 2 - ethnology
Diabetes Mellitus, Type 2 - etiology
Diabetes Mellitus, Type 2 - therapy
Diet
Diet - standards
Ethnic groups
Exercise
Family medical history
Family Relations
Health care
Healthy Lifestyle
Humans
Hypoglycemic Agents - therapeutic use
Incidence
Insulin - therapeutic use
Interprofessional Relations
Intersectoral Collaboration
Medical History Taking
Medical personnel
Metformin - therapeutic use
Minority groups
Minority Health - trends
Obesity
Obesity - complications
Obesity - ethnology
Pediatrics
Physician-Patient Relations
Poverty
Prevalence
Professional-Family Relations
Risk Factors
Societies, Medical
Teenagers
Type 2 diabetes
Type 2 diabetes mellitus
United States - epidemiology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Type 2 diabetes (T2D) is increasing in U.S. adolescents, particularly those of ethnic and racial minority groups. Risk factors for youth-onset T2D include obesity, family history of T2D, poor diet, lack of exercise, and poverty. The onset of diabetes-related complications is accelerated in adolescents with T2D compared to adults, and knowledge regarding the optimal way to prevent and slow complications is lacking. Existing treatment options are limited, and research into novel pharmacologic treatments is hindered by lack of sufficient patient population for clinical trials. Health care providers and investigators should collaborate both with each other, and with patients and their communities to build networks that will allow comprehensive evaluation of this disease in order to offer optimal, comprehensive care for these adolescents.
ISSN:1054-139X
1879-1972
DOI:10.1016/j.jadohealth.2016.12.022